Indian Pharma's Strategic Future:
A Corner Office Dialogue.
Industry leaders Nandini Piramal (Chairperson, Piramal Pharma) and Arjun Juneja (Chief Operating Officer, Mankind Pharma) dissect the decade ahead with ET's Vikas Dandekar. They discuss quality, tech, and operational shifts, providing a grounded view of leadership strategies driving the industry's competitiveness for the next 10 years.
Every medicine carries the promise of a healthier life
At the Indian Pharmaceutical Alliance (IPA), we are guided by a shared mission of Quality, Innovation, and Reach to fulfil that promise. Representing 23 of India's leading research-driven pharmaceutical companies, IPA champions policies and partnerships that strengthen India's pharmaceutical ecosystem, foster innovation, improve patient access to quality medicines, and reinforce India's position as a trusted global healthcare partner.
Innovation
that transforms healthcare
Driving an innovation-led research ecosystem to position India as a global leader in life sciences with interdisciplinary collaboration, scientific breakthroughs, and policies that enable long-term, sustainable innovation.
Inside the Lab
Quality
that builds trust
Commitment to drive excellence in pharmaceutical quality by building capabilities, benchmarking against global standards, and promoting the sharing of best practices across the industry.
Our Quality Standards
Global Reach
that expands access
Expanding global footprint of Indian companies to enhance the affordability, availability, and accessibility of quality medicines worldwide.
Track the ImpactInnovation: India's Next Growth Story
View AllQuality Reimagined for the Future
Sudarshan Jain On China Covid Scare & Its Impact On Pharma Companies
Trusted Medicine, Made for America
Can the US–India Partnership Fix Cancer Drug Shortages? | Kathleen Jaeger
Insights
External Studies 18 Dec 2025 • 15 mins
The Importance of Single Global Development of Generic and Biosimilar Medicines for Patient Access
Read More
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India's pharmaceutical sector has become the world's largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
External Study 15 May 2025 • 3 min read
Roadmap for Pharma R&D: Developing an Innovation Index as a Monitoring and Evaluation Metric
Over the past decade and more, India's pharmaceutical sector has become the world's largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
News December 22, 2025
'Eye on $500 bn by 2047, pharma steps into 2026 with focus on innovation'
Business Standard
Read More ›
News September 14, 2025
Biotech reaches for the stars, with Indian startups in tow
Fortune India
Read More ›
The Economic Times 04 Sep 2025
Crucial drugs to be more affordable after GST cut
The Economic Times
Read More ›
External Studies 18 Dec 2025 • 15 mins
The Importance of Single Global Development of Generic and Biosimilar Medicines for Patient Access
Read More
External Study 15 May 2025 • 6 min read
McKinsey: Vision 2030 - Way Forward for Indian Pharma
Over the past decade and more, India's pharmaceutical sector has become the world's largest supplier of generic medicines, with exports growing faster than the global average. The industry is at a tipping point, however....
Read More
External Study 10 May 2025 • 3 min read
Bain & Co: Healing the World - A Roadmap for Making India a Global Pharma Exports Hub
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
External Study 10 May 2025 • 3 min read
Roadmap for Pharma R&D: Developing an Innovation Index as a Monitoring and Evaluation Metric
With the Indian economy growing rapidly, the government has set an ambitious target for the nation to become a $30 trillion to $35 trillion economy by 2047. The pharmaceutical industry....
Read More
Article July 6, 2026 • 4 min read
From Pharmacy of the World to the Global Champion of Affordable Innovation
Executive SummaryIndia's pharmaceutical industry has built global trust by delivering quality, affordable medicines at scale. Today, India is the world's third-largest pharmaceutical producer by volume, supplies medicines to more than 200 countries, accounts for around 20% of the global supply of generic medicines, and has become a key contributor to global health security. India also has more than 750+ USFDA-compliant manufacturing facilities outside the United States, reflecting the industry's recognised quality and regulatory standards.As pharmaceutical value shifts towards innovation-driven medicines, biologics and advanced therapies, India's next opportunity is to complement its manufacturing leadership with innovation-led drug discovery - extending its contribution from expanding access to shaping the medicines of the future.
Read More ›
Article April 10, 2026 • 4 min read
From Global Pharmacy to Global Innovator: India's Patient-Centric R&D Evolution
Read More ›
Article January 29, 2026 • 4 min read
India Pharma's 2026 Reset: Reforms, Innovation and the Road to the Future
Read More ›
Reports February 23, 2026
Best Practices in Prevention of Contamination in Pharma Manufacturing
View Publication ›
Reports February 23, 2026
Best Practices in Sustainability in Pharmaceutical Industry
View Publication ›
Reports February 23, 2026
Best Practices in logistics and Transportation Worthiness for Pharmaceutical Product Packaging
View Publication ›
Reports February 23, 2026
Transforming Health in India: The 2030 Innovations Agenda
View Publication ›
OncoDaily TV 16 Jan 2026
Can the US–India Partnership Fix Cancer Drug Shortages? | Kathleen Jaeger
Read More ›
The Print 27 Jul 2024
Improving Quality Standards in Pharma: Global Pharmaceutical Quality Summit 2024
Read More ›
The Economic Times Pharma 28 Jun 2024
Quality Is Fundamental to Pharma and Patient Welfare: Sudarshan Jain
Read More ›
JW Marriott Juhu, Mumbai February 23, 2026
11th Global Pharmaceutical Quality Summit 2026
View More ›
Virtual October 14, 2025
IPA x McKinsey & Co. Masterclass - Pharma Launch Excellence: Global Insights
View More ›Spotlight
Mr. Satish Reddy, Chairman, Dr Reddy's Laboratories
Speaks on India's growing role in global biologics manufacturing and the innovation pipeline ahead.
Read Full Interview ›
Mr. Arjun Juneja, Chief Operating Officer, Mankind Pharma
As India scales its role in global biologics and complex generics, our real advantage will come from pairing manufacturing strength with genuine R&D depth.
Read Article ›
Glenmark Aims for 70% Revenue from Innovative Drugs Within 5–6 Years
Glenmark expects innovative products to account for nearly 70% of its revenue over the next five-six years, marking a sharp shift from its traditional generics-led model as decades of investment in drug discovery begins to pay off
Read More ›
Tariff India, and half of America’s medicine cabinet could disappear
We are in a moment of profound change around trade, onshoring, and supply chain resilience that is remaking the global economic and political order.
Read More ›Spotlight
Article:From Global Pharmacy to Global Innovator: India’s Patient-Centric R&D Evolution
For decades, India’s pharmaceutical industry has been guided by a simple principle: medicines must reach the patients who need them most. Today, nearly one in five generic medicines used worldwide is manufactured in India
Read MoreGallery
Podcast
